Jessica L. Bell

Randwick, NSW 1466, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Gene-Corrected Basal Cells Restore CFTR In Vitro; Transplants Regenerate Epithelium in a Preclinical Sinus Model.

Gene-Corrected Basal Cells Restore CFTR In Vitro; Transplants Regenerate Epithelium in a Preclinical Sinus Model.

Journal: bioRxiv : the preprint server for biology

Published: August 08, 2025

Cuproplasia-related gene signature: Prognostic insights for glioma therapy.

Cuproplasia-related gene signature: Prognostic insights for glioma therapy.

Journal: Neuro-oncology advances

Published: February 03, 2025

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Journal: Nature communications

Published: February 19, 2024

A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome.

A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome.

Journal: Human genetics

Published: October 11, 2023

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.

Journal: Molecular cancer

Published: March 23, 2023

Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.

Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.

Journal: Cell & bioscience

Published: January 25, 2023

Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient.

Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient.

Journal: Frontiers in molecular biosciences

Published: January 23, 2023

Neuroblastoma Differentiation: The Untapped Potential of Mitochondrial Uncouplers.

Neuroblastoma Differentiation: The Untapped Potential of Mitochondrial Uncouplers.

Journal: Cancer research

Published: November 15, 2022

Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy.

Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy.

Journal: Nanomaterials (Basel, Switzerland)

Published: July 14, 2022

Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer.

Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer.

Journal: Frontiers in oncology

Published: August 15, 2021

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.

Journal: Cells

Published: May 10, 2021

The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.

The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.

Journal: Frontiers in oncology

Published: December 30, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026